Oriyama T, Yamanaka N, Fujimoto J, Ichikawa N, Okamoto E
First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
J Hepatol. 1998 Jan;28(1):142-9. doi: 10.1016/s0168-8278(98)80213-4.
BACKGROUND/AIMS: Intratumor heterogeneity of DNA ploidy within a single hepatocellular carcinoma is not well understood. The present study was designed to examine the histologic distribution of intratumor DNA ploidy in hepatocellular carcinomas of different growth types in relation to cell differentiation.
Twenty patients (16 men and four women; mean age, 60.2 years) with hepatocellular carcinoma (mean diameter, 4.3 cm) were studied. One hundred and twenty-seven samples from different sites of each tumor were analyzed by determination of the nuclear DNA content and histological examination.
The DNA ploidy was heterogeneous in nine (45%) of the 20 tumors. Five tumors had a mixture of diploid and aneuploid regions, and the remaining four consisted of aneuploid regions with different DNA indices. There was no significant difference in patient characteristics between the heterogeneous and homogeneous groups. A significant correlation was found between tumor growth type and the incidence of heterogeneity. Only 16% of single nodular carcinomas without intratumor septal formation exhibited heterogeneity, while single nodular tumors with septal formation or confluent multinodular tumors were associated with high incidences of different DNA ploidy patterns or DNA indices. There was no aneuploidy in well-differentiated foci, while aneuploidy was frequently found in moderately or poorly differentiated foci (incidences of 67% and 74%, respectively).
Heterogeneity of DNA ploidy may develop along with changes in growth pattern and cell dedifferentiation or by confluence of nodules originating from different tumor cell clones.
背景/目的:单个肝细胞癌内DNA倍体的肿瘤内异质性尚未得到充分了解。本研究旨在探讨不同生长类型肝细胞癌中肿瘤内DNA倍体的组织学分布与细胞分化的关系。
对20例肝细胞癌患者(16例男性,4例女性;平均年龄60.2岁)进行研究,肿瘤平均直径4.3 cm。通过测定核DNA含量和组织学检查,对每个肿瘤不同部位的127个样本进行分析。
20个肿瘤中有9个(45%)的DNA倍体具有异质性。5个肿瘤同时存在二倍体和非整倍体区域,其余4个肿瘤由具有不同DNA指数的非整倍体区域组成。异质性组和同质性组患者的特征无显著差异。发现肿瘤生长类型与异质性发生率之间存在显著相关性。无肿瘤内间隔形成的单结节癌中只有16%表现出异质性,而有间隔形成的单结节肿瘤或融合性多结节肿瘤则与不同DNA倍体模式或DNA指数的高发生率相关。高分化灶中无非整倍体,而中度或低分化灶中常发现非整倍体(发生率分别为67%和74%)。
DNA倍体的异质性可能随着生长模式的改变、细胞去分化或源自不同肿瘤细胞克隆的结节融合而发展。